Search for: "ACTAVIS, INC." Results 21 - 40 of 382
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Mar 2014, 9:31 pm by Patent Docs
• Defendants: Actavis plc; Actavis, Inc.; Watson Laboratories, Inc.; Actavis Pharma, Inc. [read post]
4 Apr 2014, 9:32 am by Gene Quinn
On March 19, 2014, Actavis plc (NYSE: ACT) announced that it entered into an agreement with Noven Pharmaceuticals, Inc. to settle all outstanding patent litigation related to Actavis’ generic version of Daytrana® (Methylphenidate Transdermal System). [read post]
24 Jun 2013, 6:08 am by Bradley Graveline
Subsequently, Actavis, Inc. and Paddock Laboratories filed separate Abbreviated New Drug Applications pursuant to the Hatch-Waxman Act (21 U.S.C. [read post]
15 Aug 2010, 9:00 pm by Patent Docs
LLC • Defendants: Actavis Group Hf; Actavis Inc.; Actavis Elizabeth LLC; Actavis Pharma Manufacturing Private Ltd. [read post]
17 May 2015, 9:26 pm by Patent Docs
• Defendants: Actavis Laboratories FL., Inc.; Actavis Pharma, Inc.; Actavis, Inc. [read post]
19 Oct 2012, 6:13 pm by John W. Arden
For two other drugs, Watson and Actavis would be required to relinquish the marketing rights to another firm.The case is Watson Pharmaceuticals, Inc., FTC Dkt. [read post]
12 Apr 2015, 7:45 pm by Patent Docs
• Defendants: Actavis Inc.; Actavis Laboratories FL, Inc.; Activis Pharma, Inc.; Watson Laboratories, Inc.; Anda, Inc. [read post]
24 Jun 2014, 9:59 pm by Patent Docs
• Defendants: Actavis Laboratories FL Inc.; Actavis Inc.; Actavis Pharma Inc.; Watson Laboratories Inc. [read post]
19 Oct 2014, 9:14 pm by Patent Docs
• Defendants: Actavis Laboratories FL Inc.; Andrx Corp.; Actavis Inc.; Actavis Pharma Inc. [read post]
13 Dec 2009, 8:14 pm
Actavis Group et al. 1:09-cv-00940; filed December 8, 2009 in the District Court of Delaware • Plaintiffs: Cephalon Inc.; Cephalon France • Defendants: Actavis Group; Actavis Pharma Manufacturing Pvt Ltd.; Actavis Inc. [read post]
14 Jul 2022, 9:55 pm by Patent Docs
Noonan -- Almost four years ago, in a relatively rare occurrence based on there being an insufficient factual record to permit proper appellate review, the Federal Circuit vacated a District Court decision rendering invalid the claims in five patents asserted by Tris Pharma, Inc. against Teva Laboratories FL, Inc. and remanded. [read post]
15 Nov 2015, 9:32 pm by Patent Docs
• Defendant: Actavis Laboratories FL, Inc.; Actavis, Inc.; Allergan PLC Infringement of U.S. [read post]
16 May 2019, 8:15 am by Robert Schaffer & Joseph Robinson
The Federal Circuit recently affirmed a district court ruling finding patent infringement after holding that Actavis LLC, Actavis South Atlantic LLC, and Teva Pharmaceuticals USA, Inc. [read post]
6 Apr 2014, 10:00 pm by Courtenay Brinckerhoff
Actavis, Inc., the Federal Circuit reversed the district court’s decision denying Endo’s motion for summary judgment of infringement based on an implied license. [read post]
5 Jun 2016, 9:39 pm by Patent Docs
• Defendants: Actavis Elizabeth LLC; Actavis Inc. [read post]
23 Jun 2008, 11:55 am
  The products are distributed by Mylan Pharmaceuticals, Inc. under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. [read post]
1 Apr 2013, 9:59 pm by Patent Docs
Actavis (the caption for what was Federal Trade Commission v. [read post]